Skip to main content
logo
Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
7,019.00
-50.00 (-0.71%)
Jul 30, 2026, 11:30 AM JST

Chugai Pharmaceutical Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
390,439426,602540,202458,674222,169267,753
Short-Term Investments
572,134553,094456,143280,308280,938204,217
Cash & Short-Term Investments
962,573979,696996,345738,982503,107471,970
Cash Growth
-6.33%-1.67%34.83%46.88%6.60%24.65%
Accounts Receivable
381,845442,876334,256318,892512,538355,081
Other Receivables
572368961,4561,745928
Receivables
381,902443,112335,152320,348514,283356,009
Inventory
317,580276,848240,067273,480292,206208,838
Prepaid Expenses
-24,85523,01321,82718,77017,301
Other Current Assets
42,13416,24711,46611,7898,1719,543
Total Current Assets
1,704,1891,740,7581,606,0431,366,4261,336,5371,063,661
Property, Plant & Equipment
503,477479,481441,554420,701386,651352,107
Long-Term Investments
-105,51273,07361,08656,18544,663
Other Intangible Assets
59,27754,53917,86819,86025,14121,974
Long-Term Deferred Tax Assets
84,68988,30469,83564,47465,24456,287
Other Long-Term Assets
98,2821---2
Total Assets
2,449,9142,468,5952,208,3731,932,5471,869,7581,538,694

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
160,700127,24765,353112,468209,835152,266
Accrued Expenses
-53,59149,32444,62937,75134,421
Current Portion of Leases
-7,7736,3656,9756,4346,550
Current Income Taxes Payable
101,149125,721142,49971,573121,160108,293
Current Unearned Revenue
-3731317986
Other Current Liabilities
130,34096,70826,78552,54148,47125,806
Total Current Liabilities
392,189411,077290,357288,217423,730327,422
Long-Term Leases
-17,9374,5326,4807,6759,490
Pension & Post-Retirement Benefits
4,8984,2453,9353,1463,3112,945
Long-Term Deferred Tax Liabilities
4,1044,0155,0765,7877,0867,614
Other Long-Term Liabilities
21,0605,5892,9743,3373,5693,206
Total Liabilities
422,251442,863306,874306,967445,371350,677

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
73,20273,20273,20273,20273,20273,202
Additional Paid-In Capital
66,89870,51569,89669,35568,80668,223
Retained Earnings
1,879,8841,890,0421,746,9341,488,7381,293,3521,054,050
Comprehensive Income & Other
7,679-8,02711,467-5,715-10,973-7,458
Total Common Equity
2,027,6632,025,7321,901,4991,625,5801,424,3871,188,017
Shareholders' Equity
2,027,6632,025,7321,901,4991,625,5801,424,3871,188,017
Total Liabilities & Equity
2,449,9142,468,5952,208,3731,932,5471,869,7581,538,694

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-25,71010,89713,45514,10916,040
Net Cash (Debt)
962,573953,986985,448725,527488,998455,930
Net Cash Growth
-6.33%-3.19%35.83%48.37%7.25%24.12%
Net Cash Per Share
584.89579.67598.82440.92297.20277.12
Filing Date Shares Outstanding
1,6451,6461,6461,6451,6451,644
Total Common Shares Outstanding
1,6451,6461,6461,6451,6451,644
Working Capital
1,312,0001,329,6811,315,6861,078,209912,807736,239
Book Value Per Share
1232.391230.911155.56988.01865.88722.50
Tangible Book Value
1,968,3861,971,1931,883,6311,605,7201,399,2461,166,043
Tangible Book Value Per Share
1196.371197.771144.70975.94850.59709.13